Biochemical and Physical Characterization of Parvovirus Minute Virus of Mice Virus-like Particles  by Hernando, Eva et al.
dVirology 267, 299–309 (2000)
doi:10.1006/viro.1999.0123, available online at http://www.idealibrary.com onBiochemical and Physical Characterization of Parvovirus Minute Virus
of Mice Virus-like Particles
Eva Hernando,* Antonio L. Llamas-Saiz,† Concepcio´n Foces-Foces,† Robert McKenna,‡,§ Ian Portman,‡
Mavis Agbandje-McKenna,‡,§ and Jose´ M. Almendral*,1
*Centro de Biologia Molecular “Severo Ochoa” (UAM-CSIC), Universidad Auto´noma de Madrid, Cantoblanco, 28049 Madrid, Spain;
†Departamento de Cristalografia, Instituto de Quimica-Fisica “Rocasolano,” CSIC, Serrano 119, 28006 Madrid, Spain;
‡Department of Biological Sciences, University of Warwick, Coventry CV4 7AL, United Kingdom; and §Department
of Biochemistry and Molecular Biology, University of Florida, Gainesville, Florida 32610
Received September 27, 1999; accepted December 1, 1999
The VP-2 major capsid protein of the prototype strain of the parvovirus minute virus of mice (MVMp) was expressed, using a
baculovirus vector, in Sf9 insect cells. Immunogold electron microscopy of infected Sf9 cells showed VP-2 localized in the nucleus
and cytoplasm as is observed in mammalian cells during natural infections. The VP-2 subunits self-assembled into empty
parvovirus-like particles (VLPs), which appeared morphologically similar to and immunogenically indistinguishable from native
empty MVMp particles, which also contain the minor capsid protein, VP1. Incubations under different pH and temperature
conditions showed that the MVMp VLPs and native empty MVMp capsids share comparable stability. Once heated the particles
can be similarly and specifically cleaved by trypsin at the VP-2 N-terminal domain. This process mimics the further maturation of
the “rat-like” parvovirus virions, following viral DNA encapsidation, indicating that biologically relevant features of the MVMp capsid
are maintained in the VLPs. Crystals have been obtained for the MVMp VLPs which were isomorphous to those used for the
high-resolution structure determination of virions and native empty particles of the immunosuppressive strain of MVM (MVMi). The
VLP crystals diffracted X rays to beyond 3-Å resolution and are in space group C2 (a 5 448.7, b 5 416.6, c 5 306.1 Å, and b 5
95.9°). This is the first report of crystals from parvoviral particles produced in a heterologous system diffracting X rays to high
resolution, indicating that VP-2 of some parvovirus capsids can self-assemble into ordered T 5 1 icosahedral capsids in the
absence of other viral and host cell functions. © 2000 Academic Press
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The Parvoviridae includes a large number of ;5-kb
single-stranded (ss) DNA genome viruses (Berns, 1996),
pathogenic to both vertebrates and invertebrates (Siegl,
1984). The diverse biology of the parvoviruses combined
with their small particle size (approximate external ra-
dius of 140 Å) has enabled structure–function analyses
for several members of the family (Agbandje et al., 1995).
The three-dimensional structures of native particles of
“rat-like” parvoviruses (Tattersall and Cotmore, 1988) ca-
nine parvovirus (CPV) (Tsao et al., 1991; Wu et al., 1993;
Xie and Chapman, 1996), feline panleukopenia virus
(FPV) (Agbandje et al., 1993), and the immunosuppres-
sive strain of the minute virus of mice (MVMi) (Llamas-
Saiz et al., 1997; Agbandje-McKenna et al., 1998) have
been determined to high resolution using X-ray crystal-
lography. These viruses contain 60 copies of a mixture of
three capsid proteins, VP-1, VP-2, and VP-3, arranged
with T 5 1 icosahedral symmetry. The overlapping re-
gions of the capsid proteins are structurally equivalent
and contain the eight-stranded anti-parallel b-barrel
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299ound in most other known viral capsid structures (Ross-
ann and Johnson, 1989). The surface features of these
apsids include spike-like protrusions at the icosahedral
hreefold axes, a 15-Å canyon-like depression about
ach of the fivefold axes, and a dimple-like depression at
he twofold axes. The capsid surface of the human par-
ovirus B19 differs from those described above by having
epressions rather than spike-like projections at the
hreefold axes (Agbandje et al., 1994; Chipman et al.,
996). The threefold depressions function as the infec-
ious globoside receptor recognition site (Chipman et al.,
996).
The conservation of the overall parvovirus capsid to-
ology compared to their primary sequence homology
Chapman and Rossmann, 1993) suggests that the study
f more accessible members of this virus family can
rovide important information for the design of therapeu-
ic treatments against less accessible members. In this
ense, the two strains available for the murine parvovirus
VM, the fibrotropic prototype strain MVMp (Crawford,
966) and the MVMi (Bonnard et al., 1976), which differ by
nly 14 amino acids in their capsid proteins but show
ifferent target cell specificity in vitro (Crawford, 1966;
ngers et al., 1981; Segovia et al., 1991) and pathological
ffects in vivo (Kimsey et al., 1986; Brownstein et al., 1991;
0042-6822/00 $35.00
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300 HERNANDO ET AL.Ramı´rez et al., 1995, 1996; Segovia et al., 1995, 1999), may
erve as models for studying the structural determinants
f parvoviral tropism. A major determinant of tropism in
ibroblasts (Spalholz and Tattersall, 1983; Tattersall and
ratton, 1983) maps to two functionally coordinated
mino acids at positions 317 and 321 of the MVMp VP-2
apsid gene (Gardiner and Tattersall, 1988; Ball-Good-
ich and Tattersall, 1992; Maxwell et al., 1995). The X ray
rystal structure of the MVMi capsid showed that the
ibrotropic allotropic determinant was located close to
he twofold dimple-like depression at a subunit interface
Agbandje-McKenna et al., 1998). Differences in tropism
nd pathogenicity for other closely homologous parvovi-
uses have also been mapped to the capsid proteins of
leutian mink disease parvovirus (ADV) (Bloom et al.,
993), porcine parvovirus (PPV) (Bergeron et al., 1995),
PV, and FPV (Parrish et al., 1988; Chang et al., 1992;
ruyen et al., 1994) in a capsid region analogous to that
bserved for the MVMi capsid (Agbandje et al., 1993;
lamas-Saiz et al., 1996; McKenna et al., 1999). The
etermination of the MVMp capsid structure would pro-
ide a valuable means for correlating the available data
n MVM tropism to the MVMi and MVMp capsid struc-
ures, enabling a more refined definition of tropism-spe-
ific interactions for the Parvoviridae.
In the MVM capsid there are approximately nine VP-1
83 kDa) subunits per MVM particle, the balance being
ade up of VP-2 (64 kDa) in empty capsids or a mixture
f VP-2 and VP-3 (60 kDa) in full virions containing the
ncapsidated viral genome (Tattersall et al., 1976; San-
are´n et al., 1993). The VP-1 and VP-2 proteins are formed
y alternative splicing of the same pre-mRNA and as
uch the VP-2 protein is the C-terminal 64-kDa region of
he VP-1 polypeptide (Cotmore and Tattersall, 1987). In
NA-containing particles, many VP-2 proteins undergo
leavage which removes approximately 25 residues from
heir N-termini to generate VP-3 (Clinton and Hayashi,
976; Tattersall et al., 1977; Paradiso, 1981). This cleav-
ge can be mimicked in vitro using a trypsin digest,
lthough peptide mapping indicates that this cleavage
ite is not the same as that in vivo (Tattersall et al., 1977).
he N-terminal cleavage of VP-2 has been observed to
ccur only in full (DNA-containing) particles, suggesting
hat the introduction of DNA into the particle allows the
-terminus of VP-2 to be externalized. Although the same
mino acid sequence that is cleaved in VP-2 is also
resent in VP-1, the latter polypeptide is not cleaved in
ither type of particle, in vivo or in vitro (Tattersall et al.,
977). Transfection of MVM genomes determined that
he expression of VP-2 was necessary and sufficient for
he encapsidation of viral ssDNA, although only the cap-
ids which also contained VP-1 were infectious (Tullis et
l., 1993).
The baculovirus expression system using the moth
utographa californica nuclear polyhedrosis virus (AcM-
PV) infecting insect cells has been used successfully
s
bor the expression of structural components of a diverse
amily of viruses (e.g., Baumert et al., 1988; French et al.,
990; Laurent et al., 1994; Ruffing et al., 1992; Trus et al.,
995; Sanalon and Oppenheim, 1997). For the autono-
ous parvoviruses, for example, the human parvovirus
19, PPV, CPV, and ADV, parvovirus-like particles (VLPs)
ave been obtained from either VP-2 alone or VP-1 and
P-2 expressed by recombinant baculovirus (Brown et
l., 1991; Kajigaya et al., 1991; Saliki et al., 1992; Chris-
ensen et al., 1993; Sedlik et al., 1995). These parvovirus
LPs are increasingly being exploited for use as vac-
ines (Lo´pez de Turiso et al., 1992; Saliki et al., 1992;
ansal et al., 1993; Sedlik et al., 1999) and as vehicles for
oreign antigenic function delivery (Brown et al., 1994;
edlik et al., 1995). X ray crystallographic analysis of
aculovirus-expressed human parvovirus B19 VLPs, the
irst parvoviral VLPs subjected to this type of structural
nalysis, yielded only an 8-Å resolution structure (Ag-
andje et al., 1991, 1994), raising concern on the ability of
xpressed parvoviral capsid proteins to assemble cor-
ectly in heterologous systems (Agbandje et al., 1994).
igh-resolution structural analysis of native parvoviral
apsids have shown that slight surface variations be-
ween highly homologous virus strains can result in pro-
ounced antigenic differences (Agbandje et al., 1993;
lamas-Saiz et al., 1996). Thus, to aid the continued use
nd manipulation of parvoviral VLPs for successful non-
eplicative antigen delivery, it is important to know the
tructural and biological authenticity of parvovirus VLPs
ompared with native capsids.
We report here the production of VLPs of MVMp from
he expression of VP-2, the major capsid protein, using a
aculovirus system, and their comparison with native
VMp empty capsids, with respect to morphology, im-
unogenicity, thermal stability at different pHs, and sus-
eptibility to trypsin digestion. We also present prelimi-
ary X ray crystallographic data on crystals obtained for
he MVMp VLPs, isomorphous to crystals used for the
tructure determination of native MVMi virions and
mpty particles (Llamas-Saiz et al., 1997), which diffract X
ays to beyond 3-Å resolution. We verify the authenticity
f the nature of MVMp VLPs, supporting the use of
xpressed parvovirus VLPs of the members’ rat-like sub-
roup of the parvovirus genera of the Parvoviridae, for
hich MVM is a type-member, as vehicles for delivery of
ntigenic functions in vaccine development.
RESULTS
he VP-2 major capsid protein of parvovirus MVMp
xpressed in a baculovirus system reaches the
ucleus of infected insect cells and assembles
nto virus-like particles
A recombinant baculovirus expressing the VP-2 major
tructural protein of the parvovirus MVMp was obtained
y cloning the continuous VP-2 coding region down-
n
M
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a
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301MVMp PARVOVIRUS VLPs DIFFRACT X RAYS TO HIGH RESOLUTIONstream of the polyhedrin promoter into the AcMNPV
genome (Fig. 1A). Protein extracts of Spodoptera frugi-
perda (Sf9) cells infected with the Bac/VP-2p recombi-
ant baculovirus showed high levels of the correct size
VMp VP-2, while extracts of cells infected with wt
cMNPV did not (Fig. 1B). Infections with wt AcMNPV
nd Bac/VP-2p also resulted in the shutdown of host
rotein synthesis characteristic of baculovirus infections
Carstens et al., 1979).
The subcellular distribution of the expressed VP-2 in
baculovirus-infected Sf9 insect cells was examined by
electron microscopy (Fig. 2). Thin sections of infected
cells developed with an antiserum raised against native
MVMp capsids and stained by immunogold (see Exper-
imental Methods) showed gold signals in the nucleus as
well as in the cytoplasm of infected cells (Fig. 2B). This
pattern of subcellular distribution was consistent across
the 24–40 h postinfection (p.i.) interval. Similarly treated
uninfected control cells showed no gold signals (Fig. 2A).
In the isopycnic CsCl density gradient centrifugation
purification step (see Experimental Methods), fractions
banding at the appropriate density for empty parvovirus
capsids (1.32 g/ml) (Cotmore and Tattersall, 1987; San-
tare´n et al., 1993) had high hemagglutination (HA) activ-
ity, indicating the presence of MVMp VLPs. There was no
significant HA activity for fractions collected at the den-
sity corresponding to full particles. These results indi-
cate spontaneous self-assembly of MVMp VP-2 mole-
cules into empty virus-like particles when expressed in
insect cells. Once purified, these VLPs yielded a single
protein band in gels with the corresponding VP-2 size
(Fig. 1B), which was immunoreactive to MVM capsid
antiserum in immunoblotting (not shown).
MVMp VP-2 VLPs are immunogenically and
morphologically similar to native MVMp
capsids containing VP-1 and VP-2
Physicochemical characteristics of the purified VLPs
were compared with those of native empty MVMp cap-
sids purified from the natural infection of human trans-
formed NB324K cells (see Experimental Methods). The
antigenicity of both types of particles was tested by their
reactivity to a polyclonal MVMp empty capsid antiserum
(Santare´n et al., 1993) in an enzyme-linked immunosor-
bent assay (ELISA). The MVMp VP-2 VLPs were recog-
nized by the MVM antiserum, giving comparable A 490
values to those obtained for native MVM capsids across
the range of antigen dilutions studied (Fig. 3A). This
result indicates that immunodominant epitopes on the
MVMp native capsid surface are also present on the
VLPs.
Purified empty MVMp capsids and VP-2 VLPs were
examined by transmission electron microscopy after
negative staining. This analysis confirmed that the
MVMp VLPs had a similar morphology to those of nativeMVMp capsids (Fig. 3B). As with the native empty cap-
sids purified from mammalian cells, the VLPs produced
were approximately 280 Å in diameter and isometric in
appearance (Fig. 3B).
VLPs and native MVMp empty capsids share a high
stability and a specific heat-triggered externalization
of the VP-2 N-terminal domain
The relative strength of protein subunit interactions in
the MVMp VP-2 VLPs, compared with that of native
MVMp capsids, was studied by determining the stability
of both types of particles at three different pH values and
varied temperatures. The stability of the particles after
incubation at different pHs and temperatures was eval-
FIG. 1. Expression of MVMp VP-2 protein in an Sf9/baculovirus
system and purification of the resulting VLPs. (A) Genome organization
of the parvoviruses (Cotmore and Tattersall, 1987). The two parvoviral
promoters (P4 and P38) and the coded nonstructural and capsid
polypeptides are indicated. The HindIII–HpaII restriction fragment se-
lected for the VP-2 cloning under the control of the polyhedrin promoter
(PH) is indicated by downward pointing arrows. The resulting plasmid
(pBac/VP-2p) was used to obtain a recombinant baculovirus. (B) SDS–
PAGE gel stained with Coomassie blue illustrating the pattern of pro-
teins present in samples obtained from infections of Sf9 cells. Lanes
are as follows: 1, purified MVMp VLPs; 2, cells infected at high m.o.i.
with the Bac/VP-2p recombinant baculovirus at 48 h p.i.; 3, uninfected
cells; 4, cells infected with the AcMNPV wt baculovirus at 48 h p.i.
Molecular weight markers are indicated to the right.uated by a HA assay, native agarose gel electrophoresis,
and trypsin digestion.
od-sha
302 HERNANDO ET AL.At a relatively low temperature (25°C), both types of
particles efficiently hemagglutinated mouse erythrocytes
regardless of pH (Fig. 4A) in a manner similar to the HA
characteristics of CPV (Chang et al., 1992) and consistent
with the prediction recently described for the MVMi
strain (Agbandje-McKenna et al., 1998). The percentage
of hemagglutination activity only declined significantly
when the temperature was raised above 70°C, indicative
of a high stability for both types of MVMp particles. At
temperatures of 75°C and above, particle stability was
clearly dependent on pH, with the incubations at 80°C
resulting in approximately a twofold decrease in HA
activity at pH 6.0, while the HA activity was undetectable
at pH 8.8 (Fig. 4A). Intermediate values were obtained at
pH 7.5.
To verify that the HA results were a reliable measure of
particle stability and not an indication of an alteration in
erythrocytes’ binding capacity, the integrity of the native
empty MVM particles was further investigated by elec-
FIG. 2. Subcellular localization of MVMp VP-2 protein in Sf9 insect ce
with some neighboring cytoplasms subjected to immunogold labeling. (
(n) nor the cytoplasm (c). (B) Sf9 cell infected with the Bac/VP-2p recomb
expression in the nucleus and in the cytoplasm at 40 h p.i. The diso
infection is evident. Arrows indicate accumulation of gold signals. b, rtrophoresis in native agarose gels (Duda et al., 1995).
The MVMp particles showed a single band in the stainedgels (Fig. 4C) for samples incubated at temperatures up
to 75°C, with complete denaturation occurring at 80°C.
Temperature-induced conformational changes on the
MVM particles were monitored by analyzing the suscep-
tibility of the particles to trypsin digestion after heating
(see Experimental Methods). The VLPs and empty MVMp
capsids were resistant to trypsin digestion after incuba-
tion at 25°C (Fig. 4B). Both types of particles became
susceptible to trypsin digestion when heated to 70°C
and above, at pH 7.5, with the extent of the digestion
parallel to the rise in temperature (Fig. 4B). The level of
VP-2 cleavage reached approximately 50% in the parti-
cles heated at 75°C, with complete denaturation of par-
ticles occurring when heated at 80°C (Fig. 4B). The
cleavage appeared to occur specifically at the N-termi-
nus of VP-2 in both types of particles, according to the
size of the VP-3-like protein resulting from the cleavage
(arrow in Fig. 4B) and the lack of VP-1 digestion in the
native empty MVMp capsids. The results indicated that
figure shows electron micrographs of ultrathin sections of cell nuclei
fected Sf9 cell showing no immunogold staining in neither the nucleus
aculovirus showing positive gold signals (black spots) specific for VP-2
tion of the nuclear membrane structure characteristic of baculovirus
ped baculovirus nucleocapsids. Bar 5 50 nm.lls. The
A) Unin
inant b
rganizaan increase in temperature can induce local conforma-
tional changes in native empty MVMp capsids and
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303MVMp PARVOVIRUS VLPs DIFFRACT X RAYS TO HIGH RESOLUTIONMVMp VP-2 VLPs particles that externalize the N-termi-
nal domain of VP-2.
The MVMp VP-2 VLPs purified from insect cells form
stable ordered crystals that diffract X rays to beyond
3.0-Å resolution
To gain insights into the assembly status of the MVMp
VP-2 particles produced in insect cells, X ray diffraction
studies of crystals grown from the VLPs was conducted.
Crystallization of the MVMp VP-2 VLPs was successful
with the vapor diffusion hanging drop method (see Ex-
perimental Methods). Crystals, approximately 0.2–0.5
mm in the longest dimension, were reproducibly ob-
tained after a period of 4 to 6 weeks at room tempera-
ture. The MVMp VLP crystals were isomorphous to those
obtained for native full and empty particles of MVMi
(Llamas-Saiz et al., 1997). The VLP crystals diffracted X
ays to approximately 2.7-Å resolution (Fig. 5), giving an
ndication of the ordered assembly of the VP-2 subunits
n the VLPs. Between 15 to 27 useful images per crystal
ere obtained using five crystals, giving a total of 107
mages collected.
The images were successfully indexed and processed
FIG. 3. Antigenic and morphological comparisons of VP-2 VLPs with
rotein amounts of purified particles in an ELISA test using a polyc
ndependent experiments is shown. Values are above background of co
dsorbed onto carbon-coated grids and stained with uranyl acetate (mDENZO) within the resolution limits of 20–3.25 Å, scaled
ogether and postrefined (SCALEPACK) (Otwinowski,992; Llamas-Saiz et al., 1997) to give 38.5% of all pos-
ible reflections with an overall R merge
2 of 12.6% (Table 1).
The mosaic spread after postrefinement is in the range
of 0.15–0.23°. The space group is C2, with a 5 448.7,
b 5 416.5, c 5 306.1 Å, and b 5 95.9°. The reproduc-
bility and diffraction quality of these crystals have been
stablished and the collection of a complete data set for
he structure determination of the MVMp VP-2 VLPs is
nderway.
DISCUSSION
Parvovirus MVMp VP-2 was expressed using a recom-
inant baculovirus vector infecting the Sf9 insect cell
ine. The expressed VP-2 was observed in the cytoplasm
nd nucleus of infected Sf9 cells (Fig. 2). It has been
hown recently that VP-2 carries a novel nuclear local-
zation motif (NLM) that facilitates its nuclear transport
nd assembly into particles, only in the nucleus, during
atural mammalian cell infections (Lombardo et al.,
000). This NLM is only configured upon correct folding
2 Rmerge 5
¥h ¥ iu^Ih& 2 Ihiu
3 100, where the mean of the i
MVMp capsids. (A) A plot of absorbance at 490 nm versus variable
VMp capsid antiserum. A representative result of three consistent
era. (B) Electron micrographs of purified native capsids and VP-2 VLPs
ation 3100,000).native
lonal M¥h ¥Ihi
observations I hi is ^I h&.
tf
t
as th
304 HERNANDO ET AL.on VP-2 in the cytoplasm. Thus, the localization of the
expressed MVMp VP-2 in the nucleus of infected Sf9
cells indicates that the VP-2 is folding correctly in the
cytoplasm to form a NLM which enables interaction with
the nuclear transport machinery to facilitate import into
the nucleus for assembly.
The singly expressed MVMp VP-2 was able to self-
assemble into VLPs (Fig. 3), a capacity previously re-
ported in mammalian cells (Tullis et al., 1993) and now
demonstrated in a heterologous system. Purified VLPs
appeared morphologically identical to native MVMp cap-
sids containing both VP-1 and VP-2. The VLPs were
antigenically identical to native capsids, demonstrating
that the conformation of native MVMp epitopes on the
capsid surface are maintained in the VLPs. Such simi-
larities in morphology and antigenicity have also been
demonstrated for other parvovirus VLPs expressed in
heterologous systems (Brown et al., 1991; Kajigaya et al.,
1991; Christensen et al., 1993; Saliki et al., 1992). The
verification of MVMp VLP morphology and antigenicity
supports their usefulness as diagnostic antigens.
The HA assays and trypsin digestion studies verified
that the MVMp VP-2 VLPs had comparable stability to
native empty MVMp capsids when subjected to different
temperatures and pH treatments (Fig. 4). This is in con-
trast to results obtained during comparative studies of
FIG. 4. The VP-2 VLPs and native MVMp capsids show similar the
N-terminus. (A) Percentage of hemagglutination activity of empty MVM
the mean with standard errors from three independent experiments. The
limit of this assay. (B) Immunoblot analysis of the polypeptides resultin
10 min of heating at the temperatures indicated and pH 7.5. The first la
the resulting VP-3-like protein band after trypsin digestion. (C) Analysis
particles heated at the temperatures indicated. Samples are the same
purified particles was loaded per slot.VLPs and native caspids of other viruses, for example,
simian virus 40 (Sanalon and Oppenheim, 1997), where
s
eVLPs are often observed to be less stable than native
particles. Such comparative studies have not been con-
ducted for other parvoviruses for which VLPs have been
produced, thus it cannot be concluded that the compa-
rable stability observed for the MVMp particles is a
common characteristic of parvoviral VLPs.
The conversion of MVM VP-2 into VP-3-like species
(Fig. 4B) after heat treatment of native MVMp empty
particles and the MVMp VP-2 VLPs at 70°C followed by
trypsin digestion suggests the externalization of the VP-2
N-terminus due to locally induced conformational
changes (Fig. 4B), since the particles are still able to HA
at this temperature. The externalization of the N-terminus
of VP-2 for cleavage into VP-3 occurs in naturally during
viral infections for full virions, after genomic DNA pack-
aging, and is thought to be triggered by interactions
between the packaged DNA and capsid interior and
required for cell binding (Tattersall and Cotmore, 1988).
This cleavage can also be mimicked in vitro by trypsin
reatment of full virions (Tattersall et al., 1977), but has
never been previously reported for empty capsids. Struc-
tural analysis of parvoviral caspids indicate that the VP-2
N-termini are externalized through channels at the ico-
sahedral fivefold axes (Agbandje-McKenna et al., 1998)
or cleavage to VP-3 in full virions. Thus, the conforma-
ional changes induced on the native MVMp empty cap-
tability and susceptibility to the specific trypsin cleavage at the VP-2
s after heating at different temperatures at the pHs indicated. Bars are
s were consistent with different batches of erythrocytes. D.L., detection
a trypsin digestion at 37°C for 5 min (1Try) of purified particles after
the left-hand side indicates untreated material (2Try). Arrows indicate
le integrity by 1.2% agarose gel electrophoresis of MVMp native empty
ose used for the central panel in A. Four micrograms of protein fromrmal s
particle
result
g from
ne on
of particids and MVMp VP-2 VLPs by heat, which allow the VP-2
xtrusion, appear to mimic structural arrangement
305MVMp PARVOVIRUS VLPs DIFFRACT X RAYS TO HIGH RESOLUTIONevents which occur during the normal viral life cycle. The
observations suggest the possible involvement of factors
other than DNA–capsid interactions in the extrusion of
the N-terminal VP-2 domain from the capsid interior, to
allow cleavage to form VP-3, after DNA encapsidation
and prior to cell binding.
The conservation of capsid integrity after VP-2 exter-
nalization and lack of VP1 exposure in native empty
MVMp after heat treatment at temperatures up to 70°C
are consistent with previous reports (Cotmore et al.,
1999). At 80°C, the particles are presumably broken into
subviral complexes, not seen in the agarose gels, with
multiple exposed sites for trypsin cleavage (Fig. 4).
These data suggest that the T 5 1 parvovirus capsid is
unlikely to undergo the volume expansion found during
the maturation pathway of some phages (Duda et al.,
1995).
Crystals were obtained from purified MVMp VP-2 VLPs
under established conditions (Llamas-Saiz et al., 1997),
which diffract X rays to beyond 3.0-Å resolution (Fig. 5).
To our knowledge, this is the first report of parvovirus
VLP crystals diffracting X rays to high resolution. These
results show that an ordered assembly of MVMp capsids
can take place in the absence of the minor capsid pro-
tein VP-1 and nonstructural protein functions in a heter-
ologous system. The high-resolution X ray diffraction
characteristics of the crystals obtained from the MVMp
FIG. 5. A 0.3° oscillation X-ray diffraction pattern obtained from a
crystal of baculovirus-expressed MVMp VLPs. The image was taken at
the Daresbury Laboratory X ray Synchrotron Source, Station 9.6, with
an exposure time of 1 min and a crystal-to-detector distance of 500 mm,
using a wavelength of 0.87 Å. Reflections can be seen to the edge of
the image plate, which correspond to below 3-Å resolution.VP-2 VLPs crystals is in contrast to low-resolution dif-
fraction characteristics of crystals grown for human par- ovovirus B19 VLPs (Kajigaya et al., 1991), which diffracted
X rays to 8-Å resolution (Agbandje et al., 1991, 1994). A
low-resolution diffraction pattern is an indication of dis-
order in the crystal lattice. Extensive purification of the
expressed B19 VLPs (Agbandje-McKenna and Brown,
unpublished results) did not improve the diffraction qual-
ity of the crystals obtained. Disorders in virus crystal
lattices are most likely to occur if the population of
particles forming the lattice are heterogeneous. Thus the
low-resolution diffracting quality of the B19 VLP crystals
may be due to either the lack, in insect cells, of the
appropriate mammalian cellular factors with chaperone-
like functions which may normally guide the correct fold-
ing/self-assembly of B19 particles (Agbandje-McKenna
et al., 1994) or the inability of expressed proteins to reach
the nuclear compartment for correct assembly. The nu-
clear compartment appears to be required for the as-
sembly of the MVM capsid (Lombardo et al., 2000) and
MVMp VP-2 was localized in the nucleus of infected
insect cells. In contrast, the subcellular localization of
baculovirus-expressed B19 VLPs appears to be mainly in
the cytoplasm of the insect cells (Brown et al., 1991;
Kajigaya et al., 1991; Caroline Brown, personal commu-
nication). Interestingly, the NLM of MVM (Lombardo et
al., 2000), which is strictly conserved in rat-like parvovi-
ruses, is not present in the B19 capsid proteins (Chap-
man and Rossmann, 1993), raising the possibility that the
as yet unidentified nuclear localization sequences of B19
capsid proteins may not function in insect cells. The
results obtained with the MVMp VP-2 indicates that
MVMp capsid assembly does not require a permissive
mammalian environment, but most likely relies on an
inherent VP-2 folding and assembly capacity, although in
mouse cells the nonstructural protein NS-2 has been
TABLE 1
Diffraction Data Statistics in Resolution Shells
for MVMp VP-2 VLP Crystals
Resolution Å Linear R merge
a
% data
available
No. of
unique reflections
20.00–6.91 0.082 36.6 32,330
6.91–5.53 0.104 38.8 34,045
5.53–4.84 0.114 39.6 34,743
4.84–4.40 0.124 40.2 35,221
4.40–4.09 0.142 40.3 35,338
4.09–3.85 0.159 40.4 35,415
3.85–3.66 0.173 40.0 35,020
3.66–3.50 0.202 39.8 34,829
3.50–3.37 0.241 39.1 34,300
3.37–3.25 0.264 30.4 26,593
Overall 0.126 38.5 337,834
a Rmerge 5
¥h ¥ iu^Ih& 2 Ihiu
3 100, where the mean of the i
¥h ¥Ihi
bservations I hi is ^I h&.
306 HERNANDO ET AL.shown to be necessary for high levels of capsid produc-
tion (Cotmore et al., 1997).
The ordered assembly of MVMp VLPs and the heat-
induced externalization of VP-2 N-terminus that mimics
the structural transition found in DNA-full virions opens
up the possibility for their use as diagnostic antigens as
well as their use in the delivery of foreign genes and
designed biomolecules to specific cell populations. To
understand this aim and the requirement of VP-1 for
infectivity, X ray crystallographic structural studies to
elucidate the nature of (i) protein–protein interactions at
the capsid surfaces of MVMp and MVMi (Agbandje-
McKenna et al., 1998) driving permissive host infection
and (ii) factors governing the encapsidation of genomic
DNA (Tsao et al., 1991; Xie and Chapman, 1996; Ag-
bandje-McKenna et al., 1998) into virions and foreign
genes into VLPs are underway.
EXPERIMENTAL METHODS
Cells and viruses
The prototype strain of the murine parvovirus minute
virus of mice, MVMp, was grown and reference titers
were obtained by plaque assay in the mouse fibroblast
cell line A9 as previously described (Ramır´ez et al., 1995).
Large-scale production of MVMp native capsids was
carried out using the human SV40-transformed fibro-
blasts cell line NB324K (Tattersall and Bratton, 1983;
Segovia et al., 1991). The mammalian cells were cultured
in Dulbecco’s medium supplemented with 5% fetal calf
serum (FCS). Sf9 insect cells were cultivated in suspen-
sion in spinner flasks or as monolayer cultures at 27°C
in TC100 medium supplemented with 10% FCS. The Au-
tographa californica nuclear polyhedrosis virus (AcM-
NPV) and recombinant derivatives were plaque purified
and titers were obtained by plaque assay in the Sf9 cells
(Brown and Faulkner, 1977). MVMp VLPs were obtained
by infecting Sf9 insect cells growing in suspension with
a recombinant baculovirus expressing high levels of
VP-2 (see below) at an m.o.i. of 0.5 PFU/cell followed by
incubation at 27°C for 70 h.
Construction of the recombinant MVMp VP-2
baculovirus
The complete coding sequence of the VP-2 gene of a
molecular clone of MVMp (Ramır´ez et al., 1995) was
recovered as a blunt HindIII–HpaII restriction fragment of
2390 nucleotides long from an agarose gel and cloned
under the control of the polyhedrin promoter at the
BamHI site of the 5.53-kb vector plasmid pBacPAK9
(Clontech) filled in with Klenow enzyme (Boehringer).
This construct was introduced into Sf9 cells by liposome
transfection (Lipofectine, Gibco) together with a Bsu 36I-
linearized AcMNPV dsDNA (Kitts and Possee, 1993), and
putative recombinant viruses were plaque purified fromthe same cells. A series of recombinant baculoviruses
were individually tested for MVMp VP-2 expression by
small-scale infection of Sf9 cells and immunoblotting
with MVM capsid antiserum. A recombinant baculovirus
(Bac/VP-2p) expressing the highest level of VP-2 was
selected for further analysis. Recombinant baculovirus
stocks were produced by infection of Sf9 cells with Bac/
VP-2p at an m.o.i. of 0.2 for 1 h at 27°C. The cells were
transferred to 100-ml Spinner flasks and stirred for 3
days at 27°C. Virus inocula were obtained from the
supernatants of the cultures after low-speed centrifuga-
tion and stored at 4°C.
Electron microscopy
The subcellular localization of the MVMp VP-2 in Sf9
cells during infection with Bac/VP-2p was examined by
thin-section electron microscopy and immunogold label-
ing of cells infected at an m.o.i. of 5.0. Sf9 cells infected
with Bac/VP-2p were washed twice in cold phosphate-
buffered saline (PBS) at 40 h p.i. and fixed with 0.25%
glutaraldehyde, 4% paraformaldehyde in 0.1 M phos-
phate buffer (pH 7.2) for 1 h at 4°C. Fixed cells were
centrifuged in a microcentrifuge and embedded in 10%
gelatin, cryoprotected with 2.3 M sucrose, and frozen in
liquid nitrogen. Sample blocks were transferred into a
Leica AFS system and freeze substitution was carried
out in methanol with 0.5% uranyl acetate for 2 days at
280°C. Dehydration was continued with pure methanol
by raising the temperature to 230°C at a rate of 5°C/h,
and samples were infiltrated with Lowicryl K4M and
polymerized by irradiation with UV light at 230°C. For
postembedding immunogold labeling, ultrathin cell sec-
tions (50–90 nm), mounted onto grids, were reacted with
an MVM capsid antiserum raised in rabbits (Santare´n et
al., 1993) diluted 1:20 in PBS with 1% bovine serum
albumin (BSA) for 1 h at room temperature, washed with
PBS, and further incubated for 45 min with colloidal gold
of 10-nm diameter conjugated to goat anti-rabbit immu-
noglobulin G (Biocell Research Laboratory). This was
followed by rinsing in PBS and distilled water before
negative staining for 40 s with 2% uranyl acetate.
For the morphological analysis of MVMp VP-2 VLPs
and native MVMp capsids, purified particles were ad-
sorbed to glow-discharged carbon-collodion-coated
grids for 3 min and negatively stained with 2% aqueous
uranyl acetate for 50 s. Samples were examined with a
JEOL JEM 1010 transmission electron microscope oper-
ated at 80 kV. Magnification was controlled with a grating
replica.
Purification of MVMp VLPs and native capsids
The purification of MVMp VP-2 VLPs was based on
published procedures (Tattersall et al., 1976; Santare´n et
al., 1993) with some modifications. Infected Sf9 cells
were pelleted and resuspended at 109 cells per 6 ml of
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Triton X-100) supplemented with proteases inhibitors (1
mM phenylmethylsulfonyl fluoride; 10 mg/ml aprotinin; 10
mg/ml pepstatin) and freeze-thawed three times, and
debris was removed by low-speed centrifugation in a
Sorvall SS34 rotor (10,000g, 15 min, 4°C). The superna-
tant was loaded over a sucrose cushion (20% w/v in 50
mM Tris–HCl, pH 8.0, 100 mM NaCl, 1 mM EDTA, 0.2%
Triton X-100, and inhibitors as above) and centrifuged in
a Kontron TST 28.38 rotor at 35,000g at 10°C for 18 h. The
pellet was resuspended in 3.5 ml of 50 mM Tris–HCl, pH
8.0 (containing 1 mM EDTA and 0.2% Triton X-100) (TET
buffer), per 109 cells of the original culture, layered onto
sucrose gradient (10–40% w/v in 25 mM Tris–HCl, pH
.0, 10 mM NaCl, 1 mM EDTA, 2 mM MgCl2, 0.2% Triton
-100), and centrifuged in a Kontron TST 28.38 rotor at
8,000g for 6.5 h at 5°C. The gradient was fractionated,
nd the fractions were tested for HA activity with mouse
rythrocytes. Fractions with HA activity were pooled and
ialyzed overnight against TET buffer. The dialyzed sam-
le was subjected to a CsCl gradient in TET buffer (1.38
/ml average density—measured by refractive index)
nd centrifuged to equilibrium at 150,000g in a Kontron
FT 80.13 rotor for 42 h at 10°C. Finally, fractions with a
ensity corresponding to empty MVM particles (1.32
/ml) were pooled and extensively dialyzed against 10
M Tris–HCl, pH 7.5. Protein concentration was deter-
ined by 10% SDS–PAGE and by optical density read-
ngs at 280 nm using a solution of BSA as a standard.
ecoveries of purified VLPs were in the range of 4 mg of
rotein per liter of infected culture.
The MVMp empty native capsids were purified from
ultures of NB324K cells infected at a low m.o.i. and
rocessed following a previously described protocol
Santare´n et al., 1993) with the addition of a centrifuga-
ion step through a sucrose gradient, as described above
or the MVMp VLPs, followed by the equilibrium centrif-
gation in a CsCl gradient.
nzyme-linked immunosorbent assay
Graded amounts of purified particles in PBS with 7
mg/ml of BSA (New England Biolabs) were coated onto
flat-bottom well microtiter plates (Nunc) overnight at 4°C.
Plates were blocked for 1 h at 37°C with 2% BSA (Sigma,
Fraction V) in 150 mM NaCl, 0.05% Tween 20 and washed
three times with PBS containing 0.05% Tween 20. Plastic-
bound particles were then reacted in triplicate with an
MVMp empty capsid antiserum raised in rabbits (San-
tare´n et al., 1993) at a 1:1000 dilution in PBS with 0.05%
ween 20. Bound antibodies were detected with a
:10000 dilution of a peroxidase-conjugated goat anti-
abbit IgG (Jackson). After washing as above, we devel-
ped the color following a previously described proce-
ure (Segovia et al., 1995). The A 490 was read in an ELISA
reader (MultiscanMS; Labsystem).
s
cAnalysis of thermal stability of virus particles
Equivalent amounts of purified VLPs and native MVMp
capsids (0.5 mg in 20 ml of cold 10 mM Tris–HCl buffered
at pHs 6.0, 7.5, or 8.8) were aliquoted, simultaneously
heated for 10 min in water baths at 25, 70, 75, 80, or
85°C, and shock frozen in dry ice. Heated samples were
diluted in PBS (pH 7.2) and assayed for HA activity with
mouse erythrocytes. Alternatively, the integrity of the
MVM particles was determined by electrophoresis in
neutral 1.2% agarose gels as previously reported (Duda
et al., 1995).
Trypsin digestion
Small aliquots of purified VLPs and native MVMp cap-
sids were subjected to different temperatures and pHs,
diluted in 50 mM Tris–HCl, pH 8.8, 5 mM EDTA, and
incubated with 1 mg of trypsin (sequencing grade, Boehr-
inger) per 100 ng of protein, in 50 ml, for 5 min at 37°C.
hese conditions had been previously reported to effi-
iently convert VP-2 to VP-3 in DNA-containing MVM
irions (Tattersall et al., 1977). The extent and specificity
f trypsin cleavage of VP-1 and VP-2 proteins were mon-
tored by immunoblot. Samples were resolved on SDS–
0% PAGE and electrotransferred onto nitrocellulose
embranes at 100 V for 1 h. Filters were blocked with
0% horse serum in PBS and incubated with an MVM
apsid antiserum (Santare´n et al., 1993), diluted 1:2000 in
he same solution. The bound antibodies were visualized
y further incubation with a horseradish peroxidase-
onjugated secondary antibody, diluted at 1:10000 (Jack-
on ImmunoResearch Laboratories, Inc.), enhanced
hemiluminescence, (ECL, Amersham International plc)
nd autoradiography. Exposure to Kodak X-Omat films
as performed for 5 to 30 s.
rystallization and X ray diffraction analysis
Crystals of MVMp VLPs were obtained from purified
aterial, resuspended at a concentration of 10 mg/ml in
0 mM Tris–HCl, pH 7.5, using the hanging drop vapor
iffusion method (McPherson, 1982) with polyethylene
lycol 8000 and CaCl2 z 2H2O as precipitants. The same
onditions had previously produced crystals for native
irions of the MVMi strain (Llamas-Saiz et al., 1997). X ray
iffraction data were obtained from the crystals at the
aresbury Laboratory Synchrotron source, Station 9.6,
sing a Mar 30-cm image plate detector system. The
ata were collected at 4°C using oscillation angles of
.25 or 0.30°. A crystal-to-image plate distance of 450 or
00 mm was selected to obtain at least 3.0-Å resolution
ragg reflections for a wavelength of 0.87 Å. The beam
as collimated to 0.2 mm. Exposure times ranged from
0 to 120 s, depending on crystal size and beam inten-
ity. No attempts were made to align the crystals opti-
ally and no setting photographs were taken in order to
308 HERNANDO ET AL.preserve the crystals against radiation damage. The dif-
fraction images were indexed and processed with the
program DENZO and scaled using SCALEPACK (Otwi-
nowski, 1992) to 3.25-Å resolution, on a Silicon Graphics
Indigo 2 workstation and a DECalpha AXP-600 worksta-
tion.
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